H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Palatin Technologies (PTN - Research Report) today and set a price target of $70.00. The company's shares opened today at $5.25.Pantginis covers the Healthcare sector, focusing on stocks such as PDS Biotechnology, Palatin Technologies, and Applied Genetic Technologies. According to TipRanks, Pantginis has an average return of -27.1% and a 23.06% success rate on recommended stocks. Palatin Technologies has an analyst consensus of Moderate Buy, with a price target consensus of $60.00.See the top stocks recommended by analysts >>Based on Palatin Technologies' latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of $770.
https://www.tipranks.com/news/blurbs/h-c-wainwright-reaffirms-their-buy-rating-on-palatin-technologies-ptn-2?utm_source=advfn.com&utm_medium=referral